Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Native T1 mapping of the heart - a pictorial review.

Germain P, El Ghannudi S, Jeung MY, Ohlmann P, Epailly E, Roy C, Gangi A.

Clin Med Insights Cardiol. 2014 Dec 1;8(Suppl 4):1-11. doi: 10.4137/CMC.S19005. eCollection 2014. Review.

2.

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: The Randomized, Multicenter ITALIC Trial.

Gilard M, Barragan P, Noryani AA, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berland J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Endresen K, Benamer H, Kiss RG, Ungi I, Boschat J, Morice MC.

J Am Coll Cardiol. 2015 Mar 3;65(8):777-86. doi: 10.1016/j.jacc.2014.11.008. Epub 2014 Nov 16.

PMID:
25461690
3.

Identification of a new dysfunctional platelet P2Y12 receptor variant associated with bleeding diathesis.

Lecchi A, Razzari C, Paoletta S, Dupuis A, Nakamura L, Ohlmann P, Gachet C, Jacobson KA, Zieger B, Cattaneo M.

Blood. 2015 Feb 5;125(6):1006-13. doi: 10.1182/blood-2013-07-517896. Epub 2014 Nov 26.

PMID:
25428217
4.

Impact of manual thrombectomy on myocardial reperfusion as assessed by ST-segment resolution in STEMI patients treated by primary PCI.

Messas N, Hess S, El Adraa A, Ristorto J, Goïorani F, Brocchi J, Radulsecu B, Jesel L, Zupan M, Ohlmann P, Morel O.

Arch Cardiovasc Dis. 2014 Dec;107(12):672-80. doi: 10.1016/j.acvd.2014.07.044. Epub 2014 Sep 11.

PMID:
25219758
5.

Prehospital ticagrelor in ST-segment elevation myocardial infarction.

Montalescot G, van 't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WM, Swahn E, Collet JP, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW; ATLANTIC Investigators.

N Engl J Med. 2014 Sep 11;371(11):1016-27. doi: 10.1056/NEJMoa1407024. Epub 2014 Sep 1.

6.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

7.

Does optical coherence tomography optimize results of stenting? Rationale and study design.

Meneveau N, Ecarnot F, Souteyrand G, Motreff P, Caussin C, Van Belle E, Ohlmann P, Morel O, Grentzinger A, Angioi M, Chopard R, Schiele F.

Am Heart J. 2014 Aug;168(2):175-81.e1-2. doi: 10.1016/j.ahj.2014.05.007. Epub 2014 May 24.

PMID:
25066556
8.

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.

Collet JP, Silvain J, Barthélémy O, Rangé G, Cayla G, Van Belle E, Cuisset T, Elhadad S, Schiele F, Lhoest N, Ohlmann P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G; ARCTIC investigators.

Lancet. 2014 Nov 1;384(9954):1577-85. doi: 10.1016/S0140-6736(14)60612-7. Epub 2014 Jul 15.

PMID:
25037988
9.

Mitral valve surgery for transient severe mitral regurgitation: an alternative to medical treatment?

Messas N, Samet H, Brocchi J, Billaud P, Kremer H, Jesel L, Ohlmann P, Morel O.

Int J Cardiol. 2014 Aug 20;175(3):e40-2. doi: 10.1016/j.ijcard.2014.05.041. Epub 2014 May 17. No abstract available.

PMID:
24874900
10.

Left ventricular rupture after embolic myocardial infarction due to mitral valve endocarditis.

Caspar T, Delabranche X, Mazzucotelli JP, Samet H, Morel O, Ohlmann P.

Echocardiography. 2014 Apr;31(4):E104-6. doi: 10.1111/echo.12508. Epub 2014 Jan 21.

PMID:
24447262
11.

Microcirculation in hypertensive patients.

Jung F, Pindur G, Ohlmann P, Spitzer G, Sternitzky R, Franke RP, Leithäuser B, Wolf S, Park JW.

Biorheology. 2013;50(5-6):241-55. doi: 10.3233/BIR-130645. Review.

PMID:
24398607
12.

Reply to the letter by Ando et al.

Morel O, Mikail N, Jesel L, Hess S, Ohlmann P, Imperiale A.

Int J Cardiol. 2013 Oct 12;168(5):5112. doi: 10.1016/j.ijcard.2013.07.239. Epub 2013 Aug 2. No abstract available.

PMID:
23968717
13.

Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation.

Hechler B, Ohlmann P, Chafey P, Ravanat C, Eckly A, Maurer E, Mangin P, Isola H, Cazenave JP, Gachet C.

Transfusion. 2013 Jun;53(6):1187-200. doi: 10.1111/j.1537-2995.2012.03923.x. Epub 2012 Oct 15.

PMID:
23067365
14.

Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway?

Mikail N, Hess S, Jesel L, El Ghannudi S, El Husseini Z, Trinh A, Ohlmann P, Morel O, Imperiale A.

Int J Cardiol. 2013 Jun 5;166(1):248-50. doi: 10.1016/j.ijcard.2012.09.116. Epub 2012 Oct 8. No abstract available.

PMID:
23058349
15.

The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Ohlmann P, Lecchi A, El-Tayeb A, Müller CE, Cattaneo M, Gachet C.

Purinergic Signal. 2013 Mar;9(1):59-66. doi: 10.1007/s11302-012-9329-0. Epub 2012 Aug 15.

16.

The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight.

Morel O, El Ghannudi S, Hess S, Reydel A, Crimizade U, Jesel L, Radulescu B, Wiesel ML, Gachet C, Ohlmann P.

Thromb Haemost. 2012 Aug;108(2):338-48. doi: 10.1160/TH11-12-0876. Epub 2012 Jun 28.

PMID:
22740070
17.

Registry of transcatheter aortic-valve implantation in high-risk patients.

Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carrié D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R, Delpine S, Souteyrand G, Favereau X, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Van Belle E, Laskar M; FRANCE 2 Investigators.

N Engl J Med. 2012 May 3;366(18):1705-15. doi: 10.1056/NEJMoa1114705.

18.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators.

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24.

19.

Association of estimated GFR with platelet inhibition in patients treated with clopidogrel.

Muller C, Caillard S, Jesel L, El Ghannudi S, Ohlmann P, Sauleau E, Hannedouche T, Gachet C, Moulin B, Morel O.

Am J Kidney Dis. 2012 Jun;59(6):777-85. doi: 10.1053/j.ajkd.2011.12.027. Epub 2012 Mar 15.

PMID:
22425260
20.

Prehospital abciximab in ST-segment elevation myocardial infarction: results of the randomized, double-blind MISTRAL study.

Ohlmann P, Reydel P, Jacquemin L, Adnet F, Wolf O, Bartier JC, Weiss A, Lapostolle F, Gaultier C, Salengro E, Benamer H, Guyon P, Chevalier B, Catan S, Ecollan P, Chouihed T, Angioi M, Zupan M, Bronner F, Bareiss P, Steg G, Montalescot G, Monassier JP, Morel O.

Circ Cardiovasc Interv. 2012 Feb 1;5(1):69-76, S1. doi: 10.1161/CIRCINTERVENTIONS.111.961425. Epub 2012 Feb 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk